NUF2 and lung adenocarcinoma: Previous evidence demonstrate that NUF2 plays as a prognostic biomarker and therapeutic target in hepatocellular carcinoma, breast cancer, and oral cancer (7–9), and NDC80 complex gene might be an early indicator of diagnosis and prognosis of lung adenocarcinoma (10).